As the five-year anniversary of the No Surprises Act’s passage approaches, patients are still waiting for rules implementing ...
Health Affairs' Rob Lott interviews Matthew Rae, Associate Director of the Health Care Marketplace Program at KFF, about his ...
As the Center for Medicare and Medicaid Innovation moves forward with additional drug-focused models, our Part D Senior ...
Exclusionary immigration policies harm immigrants’ health and the health of nonimmigrants in the US. The current immigration ...
Highly touted efforts to cut health care spending, such as the recently passed One Big Beautiful Bill Act, ignore the real ...
A recent advisory opinion further chips away at potential liability associated with health care organizations providing ...
Health Affairs' Jeff Byers welcomes Rachel Sachs from Washington University in St. Louis and Deputy Editor Chris Fleming back ...
In the face of exclusionary immigration policy, policy makers and health advocates can help protect the health of immigrant ...
No monitoring and measurement effort will be more important to the long-term health of communities than understanding and ...
While recent fertility drug-related announcements by the Trump administration could result in savings for women—especially ...
Funding for HIV care and prevention are key for continued progress, but recent cuts to federal funding for health agencies, ...
In any review of mifepristone, the FDA will now have to grapple with Judge Otake’s conclusion that the 2023 REMS decision for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results